UBS Downgrades Xylem (XYL) to Neutral
UBS analyst Joshua Spector downgraded Xylem (NYSE: XYL) from Buy to Neutral with a price target of $132.00 (from $152.00).The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
